| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.008 |